|
|
Symposium
Program of ISODD2008
| |
AM Session |
PM Session |
Eve Session |
All Day |
Tue
Oct 14 |
Booth set up by Exhibitors
Registration from 9 am to 7 pm |
Opening
&
Welcome Reception
6 pm to 9 pm |
|
Wed
Oct 15 |
Plenary lectures
&
Exhibition Opens |
Invited lectures
&
Poster Presentations |
Poster Presentations
(workshop) |
Exhibition
Mini Trip (optional) |
Thu
Oct 16 |
Plenary lectures |
Invited lectures
&
Poster Presentations |
Poster Presentations Mini Trip (optional)
(workshop) |
Exhibition
Mini Trip (optional) |
Fri
Oct 17 |
Invited lectures
&
Poster Presentations |
Invited lectures
&
Keynote Speaker |
Closing
&
Conference Dinner |
Exhibition (Tear down from 2 pm)
Mini Trip (optional) |
Sat
Oct 18 |
Departure after breakfast
Optional Post-Conference Tours A, B, C, D (the price is not include the registration fee) |
Schedule
of ISOSDD’08 Technical Program
Day
1-
October 14, 2008, Tuesday
|
8:30 - 18:00 |
Arrival and Registration
(Main hall of
Zhongshan Hotel)
|
|
18:00 - 21:00 |
Welcome |
Opening Ceremony and
Reception Banquet
(First floor of Main
Building)
Guo-Qiang Lin, Rao
Rapaka, Yi Pan |
|
Plenary Lecture 01 |
Chiarman：Mingde
Xia (SAPA)
Stephen Scypinski (Bristol-Myers
Squibb)
Overview of the
Drug Development Process: Assuring Product Quality and Efficacy |
|
|
|
Day 2-
October 15, 2008 – Wednesday morning
|
8:00 - 8:30 |
Welcome
|
Opening Ceremony (Huangpu
Hall of the hotel)
Guo-Qiang Lin, Yi Pan, Jun Chen (President of NJU), Mingde Xia (SAPA) |
Chairman:
Biao
Jiang
(SIOC, CAS)
|
|
8:30 - 9:15 |
Plenary Lecture 02
|
Philip S.
Portoghese (University
of Minnesota)
Ligands that
activate heterodimeric opioid receptors: functional and clinical
relevance |
|
9:15 - 10:00 |
Plenary Lecture 03
|
Xiyan Lu (Shanghai
Institute of Organic Chemistry, CAS)
Paladium(II)
catalyzed addition of arylboronic acids to carbon-heteroatom
multiple bonds. An enantioselective, catalytic
Grignard
type reaction |
|
10:00 - 10:20 |
Coffee Break
|
Chairman:
Lutz F.
Tietze
(Universität Göttingen)
|
|
10:20 - 11:05 |
Plenary Lecture 04 |
Mauricio Futran (Bristol-Myers Squibb)
Knowledge Creation in Pharmaceutical Process Development in the
Context of Global Partnerships |
|
11:05 - 11:50 |
Plenary Lecture 05 |
Chen Li ( Roche-China)
Regulation of
Signals through Protein-Protein Interaction: 15 years and
counting |
|
11:50 - 12:35 |
Plenary Lecture 06 |
Peter W. Schiller (Clinical Research Institute of
Montreal, Canada)
Use of Novel Amino Acid Analogues in the Development of
Peptides as Drugs or Pharmacological Tools |
|
12:35-14：00 |
Lunch
|
Day 2-
October 15, 2008 – Wednesday afternoon
Session 1: Organic Synthesis I ( Hall A)
|
|
Chairman:
Rengxiang Tan (Nanjing Univ.) |
|
14:00–14:30 |
Inivted Lecture 01
|
Dawei Ma (SIOC, CAC)
Amino Acid Promoted
Ullmann-type Coupling Reactions and Their Applications in
Organic Synthesis |
|
14:30 –15:00
|
Inivted
Lecture 02
|
Scott Snyder (Columbia University)
Achieving Synthetic Control When Nature Abandons Selectivity |
|
15:00-15:30 |
Inivted Lecture
03
|
Zhenfeng Xi (Peking Univ.)
Synthesis of multiply substituted pyrrolopyridiens, pyridines
and pyrroles |
|
15:30–16:00 |
Inivted Lecture 04
|
Biao Jiang (Shanghai Institute of Organic Chemistry, CAS)
Synthesis of Chiral Gossypol and Their Derivatives and
Evaluation of Their Anticancer Activity |
|
16:00–16:20 |
Coffee Break |
|
Chairman: Robert Shaw (Texas
Tech University) |
|
16:20–16:50 |
Inivted Lecture 05
|
Lutz F. Tietze
(Universität Göttingen)
A New Approach for a
Selective Treatment of Cancer Based on Prodrugs and Monoclonal
Antibody-Enzyme Conjugates |
|
16:50-17:20 |
Inivted Lecture 06
|
Meixiang Wang (Insitute of Chemsitry, CAS)
Enantioselective Nitrile Biotransformations and Their
Applications in the Synthesis of Natural and Bioactive Compounds
|
|
17:20-17:50 |
Inivted Lecture
07
|
LiMing Zhang
(University of Nevada, Reno)
Au-Catalyzed Cycloaddition Reactions |
Day 2-
October 15, 2008 – Wednesday afternoon
|
Session
2(a):Medicinal Chemistry Approaches to Tackling Cardiovascular
and Metabolic Diseases
(Hall
B) |
|
Chairman: P.K Jadhav (Eli Lilly
& Company, Indianapolis) / Martin Procter (Prosidion, UK) |
|
14:00–14:30 |
Inivted Lecture 08
|
Jiesheng Kang (Sanofi Aventis, USA)
HERG and the LQT
Syndrome: Background, Regulations & Non-Clinical Strategy |
|
14:30 –15:00 |
Inivted Lecture 09
|
Donald Pinto (Bristol-Myers
Squibb Company, USA)
A Next Generation
Oral Anticoagulant: The Discovery of Apixaban, a Potent,
Selective and Orally Bioavailable Factor Xa Inhibitor
|
|
15:00-15:30 |
Inivted Lecture
10
|
P. K. Jadhav (Eli
Lilly & Company, USA)
Orally bioavailable,
nonsteroidal MR antagonist LY2180176 for the treament of
hypertension |
|
15:30-15:50 |
Coffee Break |
|
Session 3: Medicinal
Chemistry Approaches to Tackling Oncology Disease
( Hall B) |
Chairman:
Joe
Shih（Lilly
Research Laboratories, Eli Lilly and Company, USA)
|
|
15:50–16:20 |
Inivted Lecture 11
|
Qun
Li
(Chief
Scientific Officer, Egret Pharma, Shanghai,
China)
Design and
Synthesis of Orally Bioavailable Akt Kinase (PKB) Inhibitors as
Anticancer Agents |
|
16:20–16:50 |
Inivted Lecture 12
|
Jim
Henry
(Discovery
Chemistry Research and Technologies, Lilly Research
Laboratories, Eli Lilly and Company, USA)
Type
II Kinase Inhibitors for the Treatment of Cancer |
|
16:50-17:20 |
Inivted Lecture 13
|
Shawn
Qian
(Associate
Director, Meidcinal Chemistry, Cytokinetics, Inc., USA)
Discovery of
Mitotic Kinesin Inhibitors as Novel Anticancer Agents |
|
17:20-17:50 |
Inivted Lecture
14
|
Joe
Shih
（Lilly
Research Laboratories, Eli Lilly and Company, USA)
The Evolution of
Lilly Oncology: From Cytotoxic Agents (Discovery and Development
of ALIMTAÒ)
to Kinase Inhibitors |
Day 2-
October 15, 2008 – Wednesday afternoon
|
Session 4:
Pharmaceutical Development
( Hall C) |
|
Chairman: Jianji Wang
(Bristol-Myers Squibb Company) |
|
14:00–14:30 |
Inivted Lecture 15
|
Robert Discordia
(Director,
Department of Process Research and Development, Bristol-Myers
Squibb Company)
The
Process Development of an MMP Inhibitor: Development and
Execution of a Crystallization Induced Dynamic Resolution |
|
14:30 –15:00 |
Inivted Lecture 16
|
Jason Huang
(Senior
Research Investigator II, Department of Analytical Research and
Development,
Bristol-Myers Squibb Company)
Analytical Role in Pharmaceutical Development and GMP Compliance |
|
15:00-15:30 |
Inivted Lecture
17
|
Joan
Ruan (Group
Leader, Department of Analytical Research and Development,
Bristol-Myers Squibb Company)
Forced Degradation Strategy |
|
15:30-16:00 |
Inivted Lecture
18
|
Thomas Colacot (Johnson Matthey Catalyst)
Highly Active,
Air-Stable Pd Catalysts for Challenging Cross-Coupling Reactions |
|
16:00–16:20 |
Coffee Break |
|
|
Chairman: Mingde Xia (SAPA) |
|
16:20–16:50 |
Inivted Lecture 19
|
Jianji Wang
(Senior
Research Investigator II, Department of Process Research and
Development, Bristol-Myers Squibb Company)
Pharmaceutical Process
Research and Development |
|
16:50-17:20 |
Inivted Lecture 20
|
Xiongwei Shi
(United Pharmatech)
Sundia's Strategies and Steps towards Meeting Client's
Requirements for Outsourcing Services |
|
17:20-17:50 |
Inivted Lecture 21
|
Jay (Jiefei) Cheng (Otsuka Maryland Medicinal
Laboratories Inc, USA)
TheYin and Yang of
theFattyAcid Oxidation Modulation |
|
17:50-19:00 |
Dinner
|
|
19:00-22:00 |
Posters
|
Day 3-
October 16, 2008– Thursday Morning
Plenary Lecture:
(Huangpu Hall of the Hotel)
|
Chairman: Zhenfeng Xi
(Peking Univ.)
|
|
8:00 – 8:45 |
Plenary Lecture 07
|
Kevin Burgess
(Texas A&M University)
Libraries of
Bivalent Peptidomimetics for Mimicking or Disrupting
Protein-Protein Interactions |
|
8:45–9: 30 |
Plenary Lecture 08
|
Guo-Qiang Lin
(SIOC, CAS and NSFC)
New Synthetic
Methodologies and Their Utilities in the Synthesis of Bio-active
Products |
|
9:30 -10:15 |
Plenary Lecture 09
|
Bruce Lipshutz
(University of California, Santa Barbara)
Green Chemistry
Using "Designer" Surfactants. Just Add Water |
|
10: 15 – 10:45 |
Coffee Break
|
|
|
Chairman
|
Dawei Ma (SIOC, CAS) |
|
10:45 - 11:30 |
Plenary Lecture 10
|
Rene Imwinkelried (Schering-Plough, USA)
Chemical Process Scale-Up Opportunities |
|
11:30 -12:15 |
Plenary
Lecture 11 |
Ralph P Volante (Lushi Tan) (Process Research,
Merck)
Asymmetric
hydrogenation/transfer hydrogenation a powerful strategy for
drug synthesis |
|
12:15– 14:00 |
Lunch
|
Day 3-
October 16–Thursday afternoon
|
Session 5: General
Medicinal
Chemistry (Hall
A) |
|
Chairman: Qidong You (China
Pharmaceutical
University)/Jianhe
Deng
(GlaxoSmithKline. Co) |
|
14:00–14:30
|
Inivted Lecture 22
|
Jianhe Deng
(GlaxoSmithKline. Co)
Encoded Library
Technology: A New Methodology for Lead Discovery
|
|
14:30 –15:00 |
Inivted Lecture 23
|
Robert Shaw
(Texas Tech University)
Antibiotic
resistance in bacteria: novel metalloenzyme inhibitors |
|
15:00-15:30 |
Inivted Lecture
24
|
Ao Zhang (Shanghai
Institute of Materia Medica, CAS)
Multi-Strategy for
Design of Dopamine D1 & Serotonin 5-HT1A Receptor Ligands. |
|
15:30–16:00 |
Inivted Lecture 25
|
Qidong You (China Pharmaceutical University)
Conformation-based design of camptothecin analogues as potent
DNA topoisomerase I inhibitors |
Day 3-
October 16–Thursday afternoon
|
Session 2(b)
:Medicinal Chemistry Approaches to Tackling Cardiovascular and
Metabolic Diseases
(Hall
B) |
|
Chairman: P.K Jadhav (Eli Lilly
& Company, Indianapolis) / Martin Procter (Prosidion, UK) |
|
14:00–14:30 |
Invited Lecture 26
|
Wenqing Yao (Incyte
Corporation, USA)
Discovery of Potent and Selective 11ßHSD1 Inhibitors: Scaffold
Hoping Approach for Novel Lead Generation Based on Medchem
Intuition |
|
14:30 –15:00 |
Inivted Lecture 27
|
Gang Zhao (Abbott, USA)
Discovery and SAR development of thienopyridones: A class of
small molecule AMPK activators |
|
15:00-15:30 |
Inivted Lecture
28
|
Martin Procter (Prosidion, UK)
Design and synthesis of orally bioavailable Glucokinase
activators |
|
15:30–16:00 |
Inivted Lecture 29
|
Hongke Liu (Nanjing
Normal University)
Interactions of
Organometallic Ruthenium Arene anticancer Complexes with DNA |
Day 3-
October 16–Thursday afternoon
|
Session 6: Chemistry
Application in Pharmaceutical Industry
( Hall C) |
Chairman:
Hua Marlon,
Zhong
(Jiangyin PharmaAdvance, Inc.)
|
|
14:00–14:30 |
Inivted Lecture 30
|
Joseph M.
Salvino
(Director,
Hit to Lead Chemistry, Cephalon, Inc)
Practical
Approaches toward Lead Finding and Lead Optimization Library
Synthesis |
|
14:30 –15:00 |
Inivted Lecture 31
|
Yonghui Wang
(Medicinal Chemistry, Oncology CEDD, GlaxoSmithKline, USA)
7TM Receptor
Antagonists: Lead Discovery Strategy and Case Studies |
|
15:00-15:30 |
Inivted Lecture
32
|
Paul (Peng) Guo
(President, AstaTech, Inc,USA)
Process Technology
Commercialization: From Target to Technology Development |
|
15:30–16:00 |
Inivted Lecture 33
|
Maotang Zhou (Chiral Quest (China), Suzhou Industrial
Park)
Advances in
Asymmetric Hydrogenation: From Innovative Ligands to Commercial
Manufacture |
|
16:00–18:00 |
Visit High-tech Zone
|
|
|
18:00-22:00 |
Keynote lecture 1
|
Chairman: Guo-Qiang
Lin
(SIOC,CAS & NSFC)
Karl Barry
Sharpless (Nobel
Laureate 2001, Chemistry, The Scripps Research Institute, USA)
TBA
|
|
Party in Nanjing High-tech
Zone
|
Day 4-
October 17, 2008– Friday Morning
|
Session 7:Organic
Synthesis III (Hall
A) |
|
Chairman: Scott Snyder (Columbia
University) |
|
8:30 –9:00 |
Inivted Lecture 34
|
Kuiling Ding (SIOC, CAS)
Development of
highly efficient chiral catalysts for asymmetric reactions:
practical synthesis of chiral drug intermediates |
|
9:00-9:30 |
Inivted Lecture 35
|
Robert Franzen
(Tampere
University of Technology)
Recent advances in the Suzuki cross-coupling reaction of
different organoboron derivatives |
|
9:30–10:00 |
Inivted Lecture
36
|
Wanzhi Chen (Zhejiang
Univ.)
Highly Efficient
Catalysts Supported by Multidentate N-Heterocyclic Carbenes for
C-C Coupling Reactions |
|
10:00-10:30
|
Inivted Lecture 37
|
Chengjian Zhu
(Nanjing
University)
Asymmetric Reactions
Catalyzed by Nitrogen-containing Catalysts
|
|
10:30–10:50 |
Coffee Break
Speech from Universal Analytical&Testing Instrument Ltd.（15min） |
|
|
Chairman: Kunlin
Ding
(SIOC, CAS)
|
|
10:50-11:20 |
Inivted Lecture 38
|
Andrei Yudin
(University of Toronto)
Protecting
Group-Free Synthesis of Complex Amines |
|
11:20-11:50
|
Inivted Lecture 39
|
Feihe Huang (Zhejiang
Univ.)
Threaded structures
based on crown ether derivative hosts |
|
11:50-12:20 |
Inivted Lecture
40
|
Mark R. Biscoe
(MIT)
A New Class of
Easily Activated Palladium Precatalysts for Facile C=N and C=C
“Cross-Coupling Reactions” |
Day 4-
October 17, 2008– Friday Morning
|
Session 8: Medicinal Chemistry (
Hall B) |
Chairman: Wenqing
Yao（Incyte
Co.) / Robert
Cherney
(Bristol-Myers Squibb Co.)
|
|
8:30 –9:00 |
Inivted Lecture 41
|
Gui-Dong Zhu
（Abbott
Laboratories, USA）
ABT-888 and Back Up,
Orally Efficacious Inhibitors of Poly(ADP-ribose) Polymerase (PARP)
for the Treatment of Cancer |
|
9:00-9:30
|
Inivted
Lecture 42
|
Matthew Bogyo (Stanford Univ.)
Small
molecule activity based probes for diagnostic imaging and drug
discovery applications |
|
9:30–10:00 |
Inivted Lecture
43
|
Hong Liu ( The Novartis Research Foundation, USA)
Structure Based
Design and
Synthesis of Noncovalent Inhibitors of Cathepsin S and Their
Applications in Treating Neuropathic Pain
|
|
10:00-10:30
|
Inivted Lecture 44
|
Weizheng (William) Xu
(MGI
Pharmaceutical, USA)
Design, Synthesis
and Biological Evaluation of PARP Inhibitors as Chemosensitizers |
|
10:30–10:50 |
Coffee Break |
|
|
Medicinal
Chemistry Approaches to Tackling Inflammation Disease |
|
10:50-11:20 |
Inivted Lecture 45
|
Li Chen
（Hoffmann-La
Roche）
Discovery of VLA4
Antagonists for the Treatment of Autoimmune Diseases |
|
11:20-11:50
|
Inivted Lecture 46
|
Robert J. Cherney (Bristol-Myers Squibb, USA)
Discovery of Potent
CCR2 Antagonists |
|
11:50-12:20
|
Inivted Lecture 47
|
Yun He (Medical Chemistry Department, Roche R&D Center
(China) Ltd)
TBA |
Day 4-
October 17, 2008– Friday Morning
Session 9: Organic Chemistry Process Chemistry
(Hall C)
|
Chairman: Yaping
Hong
(Princeton GlobalSynthesis LLC)
|
|
8:30–9:00 |
Inivted Lecture 48
|
Yannis Houpis (Johnson and Johnson PRD)
Carboxylate Directed Pd-Catalyzed Cross Coupling Reactions in
the Selective Synthesis of tri-Substituted Aromatics |
|
9:00 –9:30 |
Inivted Lecture 49
|
Zhi-Hui (Bruce) Lu (Boehringer-Ingelheim
Pharmaceuticals)
Practical Synthesis Of 2,3-Disubstituted And Polycyclic Indoles |
|
9:30-10:00 |
Inivted Lecture
50
|
Jurong Yu (Nanjing PharmaTech)
My experience of doing Process R&D in China: the Story in
Nanjing |
|
10:00-10:30 |
Inivted Lecture 51
|
Xudong Wei (Boehringer-Ingelheim Pharmaceuticals)
Practical large scale synthesis of macrocyclic hcv protease
inhibitors |
|
1030–10:50 |
Coffee Break |
|
|
Chairman: Yannis
Houpis
(J&J)
|
|
10:50-11:20 |
Inivted Lecture 52
|
Yaping
Hong
(Princeton GlobalSynthesis)
Development of Highly Efficient Chemical Processes for
Pharmaceuticals |
|
11:20-11:50
|
Inivted Lecture
53
|
Hua Marlon Zhong (Jiangyin PharmaAdvance, Inc.)
TBA |
|
11:50-12:20 |
Inivted
Lecture 54
|
Yiming
Yao (CEO of EnzMed, Nanjing)
Enzymatic synthesis in pharmaceutical development
|
Day 4-
October 17–Friday afternoon
|
Session 10:Organic
synthesis
III (Huangpu
Hall of the Hotel) |
Chairman: Wangzhi
Chen（Zhejiang
Univ.)
|
|
14:00–14:30 |
Inivted Lecture 55
|
Zhangjie Shi
(Peking Univ.)
Transition-Metal Catalyzed C-H Activation
|
|
14:30 –15:00 |
Inivted Lecture 56
|
Lei Liu
(Tshinghua
Univ.)
Chemical synthesis and
modification of proteins |
|
15:00-15: 20 |
Inivted Lecture 57
|
Yuhong
Zhang
(Zhejiang Univ)
Transition
metal-catalyzed reactions involving arynes |
|
15:20-15:40 |
Inivted Lecture 58
|
Yanxing
Jia
(Peking
University)
Palladium-catalyzed
indole and azaindole syntheis by direct annulation
of electron-poor o-chloro-anilines
and chloroaminopyridines with aldehydes |
Day 4-
October 17–Friday afternoon
|
Session 11:
Medicinal Chemistry
(
Hall B) |
Chairman: Yun
He
(Medical Chemistry Department，Roche
R&D Center (China) Ltd)
|
|
14:00–14:30 |
Inivted Lecture 59
|
Renxiang Tan
(Nanjing Univ.)
Symbionts, a
Promising Generator of New Drug-like Molecules |
|
14:30 –15:00 |
Inivted Lecture 60
|
Ya-Qiu Long (Shanghai
Institute of Materia Medica, CAS)
1,6-Naphthyridine-7-carboxamide templated active compounds:
switching from hiv-1 integrase inhibitors to anti-tumor agents
|
|
15:00-15:20 |
Inivted Lecture
61
|
Yao-Chang Xu
(Novartis AG)
Serotonin antagonist
and it’s application in smoking cessation and anti-depression. |
|
15:20–15:40 |
Inivted Lecture 62
|
Chin-Kang
Sha (National
Tsing-Hua University)
Total Synthesis of
(±)-Ottelione A |
Day 4-
October 17–Friday afternoon
|
Session12:
Outsourcing in
Chemistry and Drug Development
& 3rd Nanjing
International Pharmaceutical Research & Cooperation Conference
(Hall
C) |
Chairman: Yuanzan
Ye
(Acesys Pharmatech)
|
|
14:00–14:20 |
Inivted Lecture 63
|
Director of Nanjing High-Tech Zone
Introduction on Pharmaceutical industry Nanjing High-Tech Zone |
|
1420 –15:00 |
Inivted Lecture 64
|
Stanley Wang (Director, Genscript Corporation)
Outsourcing Biology for Accelerated Discovery |
|
15:00-15:30 |
Inivted Lecture 65
|
Dan Liu,,VP, Tripod Biopharmaceutical Group
The CRO trend and the policy of Tripod Biopharmaceuticl Group |
|
15：30-16：00 |
Inivted Lecture 66
|
Charles Ye (CEO, Acesys Pharmatech)
Integrated CRO service in Nanjing |
Day 4-
October 17–Friday afternoon
Keynote Lecture: (Huangpu
Hall of the Hotel)
|
Chairman: Yi Pan (NJU) and Guigen Li (Texas Tech. University)
|
|
16:00-16:50 |
Keynote Lecture 2
|
Avram
Hershko
(Nobel Laureate 2004, Chemistry, Technion-Israel Institute of
Technology, Israel)
TBA |
|
16:50-17:40 |
Keynote Lecture 3
|
Aaron
Ciechanover
(Nobel Laureate 2004, Chemistry, Technion-Israel Institute of
Technology, Israel)
TBA |
|
17:40-18:30 |
Closing Ceremony (Huangpu Hall of the
Hotel)
Yi Pan
and Guigen
Li
|
|
19:00-21:00 |
Farewell Party (Zijin Hall)
Yi Pan,
Rao Rapaka,
Guo-Qiang Lin
|
October 18– Saturday
Departure or trip
The conference lectures, poster sessions, lunch and
accommodation are all located within conference center.
The conference consists of keynote lectures (~50 min,
Nobel winners), plenary lectures (~45 min), invited lectures (~30 min),
invited talks (~20 min) including discussions and poster sessions. The
invited lectures are arranged as three paralleled sessions. Detailed
information will be provided in the Scientific Program.
The poster session will be started in the evening of
October 15 and remained though out the symposium.
Tour Program Accompanying person program (mini trip) From Monday Tue Oct.14, to Friday Oct.17. Optional Post-Conference
Tours A, B, C, D Three post-conference tours will be organized with reduced rates.
For detailed schedule, you can download from the list below.
You are encouraged to email us about your choice to
yxcheng@nju.edu.cn in advance.
| Tour Program |
Details |
time |
Quotation
(USD/person) |
| Tour A: |
City tour of Nanjing and Visit campus of NJU |
Morning |
Free |
| Tour B: |
Chinese traditional family gardens: Nanjing-Yangzhou-Nanjing
Detailed Schedule： English
Version 中文版 |
1 days |
Tour
Package (for a minimum of 20 people) ~$60/p |
| Tour C: |
Eastern Venetian City and Chinese classic gardens: Nanjing-Suzhou-Nanjing
Detailed Schedule： English
Version
中文版 |
2
days |
Tour
Package (for a minimum of 20 people) ~$160/p
|
| Tour D: |
Natural spectacle: Nanjing-Yellow Mountain- Nanjing
Detailed Schedule： English
Version
中文版 |
3
days |
Tour
Package (for a minimum of 20 people) ~$300/p
|
Remarks:
1. Tour A is free for all registered participants of ISOSDD2008. |
